Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

5 April 2018

QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria, United in the Fight to Cure ALS.. More

15 December 2017

QurAlis has won the Amgen Golden Ticket at LabCentral. More

1 October 2017

Ribometrix Raises $7.5M In Seed Funding to Advance Platform for Discovering and Developing Small Molecule Modulators of RNA to Treat Human Diseases. More

6 September 2017

Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer,
Advancing Leadership in Immuno-Oncology. More

4 June 2017

F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology. More

 

 

 

Featured Portfolio